Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionAffinity Asset Advisors, LLC
Latest Disclosed Ownership55,000 shares
Latest Disclosed Value $ 28,790,850
Affinity Asset Advisors, LLC ownership in YDO1 / Madrigal Pharmaceuticals, Inc.

On May 14, 2026 - Affinity Asset Advisors, LLC filed a 13F-HR form disclosing ownership of 55,000 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $24,766,500 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 31,131 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 76.67% during the quarter. The current value of the position is $23,441,000 USD.

Affinity Asset Advisors, LLC has a history of taking positions in derivatives of the underlying security (YDO1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:YDO1 / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 55,000 23,869 76.67 28,791 58.82 1.4869
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 31,131 -83,869 -72.93 18,129 -65.63 1.0330
2025-11-13 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 115,000 35,000 43.75 52,746 117.86 4.5947
2025-08-13 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 80,000 0 0.00 24,211 -8.63 3.3067
2025-05-14 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 80,000 -2,500 -3.03 26,498 4.09 2.5290
2025-02-13 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 82,500 -17,500 -17.50 25,457 19.96 3.4124
2024-11-13 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 100,000 -10,000 -9.09 21,222 -31.14 2.8962
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 110,000 -5,000 -4.35 30,818 0.35 3.5524
2024-05-14 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 115,000 15,000 15.00 30,710 32.72 3.8018
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 100,000 15,000 17.65 23,138 86.40 4.2259
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 85,000 -7,500 -8.11 12,413 -41.91 3.4918
2023-08-21 2023-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 92,500 -500 -0.54 21,368 -5.16 7.4631
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 92,500 -500 21,368 7.4504
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 93,000 23,000 32.86 22,530 10.89 7.4355
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 70,000 -30,000 -30.00 20,318 212.62 7.9680
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 100,000 0 0.00 6,499 -9.21 1.8140
2022-08-12 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 100,000 25,000 33.33 7,158 -2.73 3.0174
2022-05-13 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 75,000 10,000 15.38 7,359 33.61 1.1774
2022-02-11 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 65,000 65,000 5,508 2.0001
2021-05-14 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -5,000 -100.00 0 -100.00
2021-02-12 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,000 5,000 556 0.2947
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-21 2023-06-30 13F/A MADRIGAL PHARMACEUTICALS COM Call 53,100 12,266 n/a n/a n/a
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 53,100 12,266 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 75,000 4,874 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.